Emulate

About:

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Website: http://emulatebio.com

Twitter/X: emulateinc

Top Investors: Alumni Ventures, Qiming Venture Partners, Perceptive Advisors, Founders Fund, National Institutes of Health

Description:

Emulate is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Total Funding Amount:

$271M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

jenn.perkins(AT)emulatebio.com

Founders:

Daniel Levner, Donald Ingber, Geraldine A. Hamilton

Number of Employees:

51-100

Last Funding Date:

2024-03-20

IPO Status:

Private

Industries: